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Hans Hoppeler*
ABSTRACT
The skeletal muscle phenotype is subject to considerable malleability
depending on use as well as internal and external cues. In humans,
low-load endurance-type exercise leads to qualitative changes of
muscle tissue characterized by an increase in structures supporting
oxygen delivery and consumption, such as capillaries and
mitochondria. High-load strength-type exercise leads to growth of
muscle fibers dominated by an increase in contractile proteins. In
endurance exercise, stress-induced signaling leads to transcriptional
upregulation of genes, with Ca2+ signaling and the energy status of
the muscle cells sensed through AMPK being major input
determinants. Several interrelated signaling pathways converge on
the transcriptional co-activator PGC-1α, perceived to be the
coordinator of much of the transcriptional and post-transcriptional
processes. Strength training is dominated by a translational
upregulation controlled by mTORC1. mTORC1 is mainly regulated
by an insulin- and/or growth-factor-dependent signaling cascade as
well as mechanical and nutritional cues. Muscle growth is further
supported by DNA recruitment through activation and incorporation of
satellite cells. In addition, there are several negative regulators of
muscle mass. We currently have a good descriptive understanding
of the molecular mechanisms controlling the muscle phenotype. The
topology of signaling networks seems highly conserved among
species, with the signaling outcome being dependent on the
particular way individual species make use of the options offered by
the multi-nodal networks. As a consequence, muscle structural and
functional modifications can be achieved by an almost unlimited
combination of inputs and downstream signaling events.
KEY WORDS: Skeletal muscle, Molecular, Pathways, Myofibrils,
Mitochondria, Capillary, Strength, Endurance
Introduction: Skeletal muscle malleability
It must have been obvious for most of human history that physical
performance capacity varies massively between individuals. The
ancient Olympic games held in Greece between 776 BC and 394 AD
are testimony to the fact that these differences were appreciated and
held worthy of being exposed and celebrated. However, the
underpinning of the large differences in individual functional
performance capacity remained elusive. Astrand (1956) reviewed
the physiological limits of human performance, noting that
outstanding feats that could be achieved by athletes were the
result of both natural endowment as well as specific exercise
training. However, it was not until 1967 that Holloszy (1967)
furnished the proof that respiratory enzymes in rat skeletal muscle as
well as whole-body oxygen consumption could be increased with
stringent endurance exercise training. While before Holloszy’s
seminal paper, most physiologists saw muscle tissue as inert and
somewhat boring, research into muscle plasticity burgeoned
afterwards. Numerous scientists since have shown that skeletal
muscle in all species studied is an extremely malleable tissue. It
changes in a consistent fashion with many physiological stimuli
such as strength and endurance training (Hoppeler, 1986), disuse
(Bodine, 2013), hypoxia (Hoppeler et al., 2008), weightlessness
(Desplanches, 1997), cold exposure (Buser et al., 1982; van den
Berg et al., 2011) and nutritional modifications (Vogt et al., 2003).
Muscle tissue’s response to external stress can be rapid and
extensive. With chronic electrical stimulation, mitochondrial
content increased by as much as sevenfold in 28 days in
superficial parts of rabbit tibialis anterior muscle (Reichmann
et al., 1985). With human endurance training we have shown that the
mitochondrial complement in the vastus lateralis muscle can be
increased by more than 30% in 6 weeks of training (Hoppeler et al.,
1985). With strength training over the same time period, fiber size
and content in contractile proteins is increased by some 10% (Lüthi
et al., 1986).
Many of the underlying molecular mechanisms that are
responsible for the structural changes of muscle tissue have been
unraveled over the last two decades. The purpose of the present
review is to give a short overview of the currently known factors and
their role in skeletal muscle plasticity. It is a focused update of a
comprehensive review of the molecular mechanisms involved in
exercise-induced phenotypic malleability of skeletal muscle tissue
(Hoppeler et al., 2011).
Sensing muscle stress
During physical activity, muscle experiences specific stressors that
can challenge and disrupt homoeostasis and occasionally muscle
structural components. Muscle tissue structural and functional
adaptations then occur as a consequence of repeated stimuli. Four
major physiological stressors that are active during exercise have
been identified: mechanical load, neuronal activation, hormonal
adjustments and metabolic disturbances (Flück and Hoppeler,
2003). During exercise at a specific intensity and over a defined
period of time, muscle tissue experiences a particular blend of these
fundamental stressors. With strength training, the mechanical stress
is dominant, while during endurance exercise, mechanical stress is
low but metabolic disturbances can be severe and protracted. In any
kind of muscle activity, neuronal activation and associated Ca2+ and
other ion transients, as well as load- and duration-specific hormonal
adjustments occur. These stresses experienced during and after
physical activity are limited in time. However, they set in motion a
range of molecular events within muscle cells that aim at preparing
muscle towards similar future events. These skeletal muscle
adaptations not only offer protection from future ‘insults’, they
also generally improve skeletal muscle and whole-body
performance with regard to the specific stress experienced or the
exercise training undergone.
Much of our understanding of the molecular mechanisms
of skeletal muscle plasticity has been obtained in experiments
using cell cultures or model organisms with techniques such as
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knock-outs or knock-ins, as well as pharmacological agents
blocking or enhancing specific pathways. These techniques
provide the information necessary to map the structure of
signaling pathways and give information on how signaling
networks modify downstream targets. This approach does not
account for the transient nature of many of the physiological
stressors and may lead to complex and compensatory processes that
limit the interpretation of the importance of individual factors in
physiological adaptations (Hawley and Holloszy, 2009).
The question arises as to how the four generic physiological
stressors mentioned above interact with the cellular proteome. How
is it that muscle cells build mitochondria in response to metabolic
stress experienced with endurance training? How is it that in
strength training as few as 36 near-maximal contractions per week
leads to accretion of myofibrillar proteins in those muscle fibers that
were mechanically loaded? The generic answer to this question is
that each of the fundamental stressors is associated with a number of
signaling pathways within muscle cells that control gene expression
on the transcriptional or translational level or interfere with protein
degradation. Control of the protein pool of the muscle cell could in
principle be exerted at these three canonical sites within muscle cells
(see Favier et al., 2008). Transcriptional upregulation of gene
expression could lead to an increase in the concentration of
downstream mRNAs, which, at a constant translational rate, would
result in an increase in coded proteins. Alternatively, with a constant
rate of transcription and a constant mRNA pool, translational
upregulation could be responsible for an increase in the protein
content. Proteins must be directed to the correct location in the cell
and must properly be assembled. Last but not least, modifications
of protein degradation could also affect the size of the muscle
cell’s protein complement. Previous research showed that the
concentration of nuclear and mitochondrial coded mRNAs was
almost double in highly trained endurance runners and in proportion
to the mitochondrial content in the vastus lateralis muscle
(Puntschart et al., 1995). Pilegaard et al. (2003) demonstrated that
peroxysome-proliferator-activated receptor-γ coactivator 1 (PGC-
1α) transcription and mRNAwas transiently elevated after a bout of
endurance exercise in humans. This led to the generally accepted
notion that each repeated bout of endurance exercise is followed by
signaling and upregulation of mitochondrial gene transcripts
resulting in a cumulated response – the endurance phenotype
(Joseph et al., 2006) (Fig. 1). By contrast, the gain in muscle mass
seen with strength training is mainly regulated by activating
mammalian target of rapamycin complex 1 (mTORC1), a key
modulator of mRNA translation (see Phillips, 2009), and is not
immediately transcription dependent (Fig. 2).
Signaling in endurance exercise
PGC-1α
PGC-1α is considered to be the key downstream element of the
signaling cascades activated by endurance exercise in muscle tissue
(Chan and Arany, 2014) (Fig. 1). The PGC-1α gene is controlled by
several promoters, coupled to alternative splicing, involved in
activating gene programs for adaptations to higher energy demands
(see Martinez-Redondo et al., 2015). PGC-1α is a member of a
family of transcriptional coactivators (PGC-1α, PGC-1β and PGC-1
related coactivator) that regulate mitochondrial biogenesis and
capillarity in a wide variety of tissues. PGC-1 plays its role in the
control of energy metabolism by serving as master regulator for
coordinated programs of gene expression by a multitude of
transcription factors. Specific variants of PGC-1α are induced by
a variety of physiological cues (discussed below) increasing muscle
tissue mitochondrial content and capillarity (Rowe et al., 2014).
This is not the case for PGC-1β, which is assumed to regulate basal
mitochondrial function (see Villena, 2015). Both PGC-1α and
PGC-1β are highly expressed in skeletal muscle tissue with
expression levels higher in oxidative than in glycolytic fibers.
Although PGC-1α is generally found to be increased with exercise,
PGC-1β has been reported to actually decrease with exercise
training (Mortensen et al., 2007). However, despite the
acknowledged role of PGC-1α in induced mitochondrial
biogenesis, PGC-1α does not seem to be indispensable for
exercise-induced mitochondrial biogenesis (Rowe et al., 2012). It
is thus assumed that other, as yet undefined factors can compensate
for a lack of PGC-1α.
The regulation of the PGC-1 isoforms is complex and not fully
understood. A recently discovered splice form of PGC-1α, PGC-
1α4, has no effect on mitochondrial gene regulation. PGC-1α4 is
increased with strength training protocols associated with muscle
fiber hypertrophy (Ruas et al., 2012). These authors showed that
muscle growth by PGC-1α4 is achieved by inducing insulin-like
growth factor 1 (IGF-1) and by suppressing myostatin.
AMP-activated protein kinase
AMP-activated protein kinase (AMPK) senses the increase in
energy turnover when muscle tissue is activated. AMPK activity is
increased by binding AMP or ADP to its γ subunit. AMPK
coordinates anabolic versus catabolic processes in cells and
balances nutrient supply with energy demand (see Mounier et al.,
2015). AMPK activation has short-term actions on key metabolic
processes in skeletal muscle tissue by increasing glucose uptake and
List of abbreviations
ActRIIA/B activin type II receptor A/B
Akt protein kinase B
AMPK AMP-activated protein kinase
CaMK calmodulin-dependent kinase
CaN calcineurin
COPD chronic obstructive pulmonary disease
FAK focal adhesion kinase
FoxO forkhead box protein
GDF11 growth differentiation factor 11
HDAC histone deacetylase
HIF-1 hypoxia inducible factor 1
IGF-1 insulin-like growth factor 1
LCFA long-chain fatty acid
MEF myocyte enhancer factor
mTORC1 mammalian target of rapamycin complex 1
NFAT nuclear factor of activated T-cells
NF-κB nuclear factor kappa of activated B-cells
NO nitric oxide
PDK4 pyruvate dehydrogenase lipoamine kinase isoenzyme 4
PGC-1α peroxisome-proliferator-activated receptor gamma,
coactivator 1
PPAR peroxisome-proliferator activated receptors
REDD1 regulated in development and DNA damage responses
RNS reactive nitrogen species
ROS reactive oxygen species
SIRT-1 sirtuin 1
Smad homologs of the Drosophila protein mothers against
decapentaplegic (MAD)
TLR2/4 toll-like receptor 2/4
UPS ubiquitin-proteasome system
VEGF vascular endothelial growth factor
Wnt signaling protein (named after Wingless and Int-1 in
Drosophila)
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fatty acid oxidation and by decreasing protein synthesis.
Additionally, AMPK is involved in long-term metabolic changes
involving mitochondrial biogenesis and promoting an oxidative
muscle phenotype. While the short-term actions of AMPK are
achieved by acute phosphorylation of key regulatory proteins,
the long-term regulatory actions are mediated via direct
phosphorylation of transcription factors and the transcriptional
coactivator PGC-1α. PGC-1α is further activated by de-acetylation
of sirtuin 1 (SIRT-1) while phosphorylating histone deacetylase 5
(HDAC5) leads to indirect activation of PGC-1α through the release
of myocyte enhancer factor-2 (MEF2; see Fig. 1).
Calcium-dependent signaling
The muscle genetic programs that are activated during exercise
training are importantly influenced by Ca2+-dependent signaling.
An initial step in Ca2+ signaling is binding of Ca2+ to calmodulin.
Ca2+-activated calmodulin then interacts with downstream Ca2+
decoders of which calcineurin (CaN) and calmodulin-dependent
protein kinase II (CaMKII) have been characterized well in a
functional context (see Tavi and Westerblad, 2011). Generally
speaking, CaN and CaMKII are activated by tetanic stimulation, not
single muscle twitches, whereby the response and decay of CaN is
much more rapid than the response of CaMKII. As the decay of
activity of the Ca2+ decoders is up to 100 times slower than the Ca2+
transients, it is suggested that they servememory functions related to
the prior activation events. Ca2+ decoders modify gene transcription
by activating transcription factors such as nuclear factor of activated
T-cells (NFAT) and MEF2, and transcription modulators such as
HDACs and PGC-1α (Norrbom et al., 2004). The available
evidence indicates that the Ca2+ decoders influence muscle fiber
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Fig. 1. Simplified overview of signaling network controlling skeletal muscle adaptations with endurance type exercise (modified and updated from
Hoppeler et al., 2011). AMPK, AMP-activated protein kinase; AP-1, activator protein 1; Ang, angiopoietin; BAX, apoptosis regulator Bax (regulated by tumor
suppressor protein p53); CaM, calmodulin; CaMK, calmodulin-dependent kinase; cAMP, cyclic AMP; COX, cytochrome oxidase; CREB, cAMP response
element-binding protein; fos/jun, transcription factors, proto-oncogenes; FoxO, forkhead box protein: HIF-1, hypoxia inducible factor 1; HDAC, histone
deacetylase; HSF, heat shock factor; HSP, heat shock protein; LCFA, long chain fatty acids; LKB1, liver kinase B1; MEF, myocyte enhancer factor; MyoD,
myogenic factor 3; mtDNA, mitochondrial DNA; NFAT, nuclear factor of activated T-cells; NF-κB, nuclear factor kappa; NRF1/2, nuclear respiratory factor 1/2;
NUGEM, nuclear coded genes of mitochondria; PDGFA, platelet derived growth factor A; PGC-1α, peroxisome-proliferator-activated receptor gamma,
coactivator 1; PKA, protein kinase A; PPAR, peroxisome-proliferator-activated receptors; ROS, reactive oxygen species; RNS, reactive nitrogen species; SIRT-1,
sirtuin 1, a NAD-dependent deacetylase; TF1/2, transcription factor 1/2; TFAM, mitochondrial transcription factor A; VEGF, vascular endothelial growth factor.
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type properties under drastic conditions of denervation or chronic
electrical stimulation and also with CaN and CaMKII knock-outs or
overexpression. Their role in more physiological low-intensity and
high-intensity endurance type exercise remains to be established.
An additional way in which Ca2+ decoders could influence muscle
phenotype is through activation by shifts of basal Ca2+
concentrations during rest periods (Bellinger et al., 2008).
Reactive oxygen and nitrogen species in muscle signaling
Muscular exercise increases reactive oxygen species (ROS). It has
also been established that contracting muscle is also a source of
nitric oxide (NO) and reactive nitrogen species (RNS) (Balon and
Nadler, 1994). Initially it was widely believed that both ROS and
RNS were damaging to muscle fibers, which led to widespread use
of antioxidants in sport drinks. Over the last 15 years it was
recognized that ROS/RNS play an important role in skeletal muscle
plasticity with exercise and disuse. Superoxide in muscle is
produced in the sarcoplasmic reticulum, transverse tubules,
sarcolemma, cytosol and notably in mitochondria (see Powers
et al., 2011). It has been estimated that less than 0.15% of oxygen
consumed in mitochondria leads to superoxide formation, with
more superoxide formed at rest (St-Pierre et al., 2002). The source
of exercise-induced superoxide remains debated. It is recognized
that intracellular ROS is an important signal in muscle remodeling
with exercise. However, it is also evident that inactivity-induced
ROS production contributes to disuse atrophy. It is well established
that endurance exercise training not only leads to an oxidative
muscle phenotype but also to an improved antioxidant defense.
The molecular pathways used by ROS/RNS to modulate gene
expression to this effect, involve the transcriptional activator NF-κB
(nuclear factor of activated B-cells) and the activation of PGC-1α. It
has been noted that the suppression of ROS activity in active muscle
by antioxidants leads to a blunted NF-κB response and abolishes the
exercise induced increase in manganese superoxide dismutase, an
important antioxidant enzyme (Gomez-Cabrera et al., 2005). PGC-
1α seems to be sensitive to the redox status of the muscle cell
through multiple upstream factors (among them cAMP response
element-binding protein and MEF2). ROS have also been shown to
be able to induce transcription of PGC-1α indirectly via AMPK.
Moreover, the human PGC-1α promoter contains a binding site for
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Fig. 2. Simplified overview of signaling network controlling skeletal muscle mass with hypertrophy and inmuscle atrophy (modified and updated from
Hoppeler et al., 2011). ActRIIA/B, activin receptor protein II; Akt, protein kinase B; AMP, adenosine mono-phosphate; AMPK, AMP-activated protein kinase;
BMP, bone morphogenic protein; DGK, diacylglycerol kinase; FA, focal adhesion kinase; FGF, fibroblast growth factor; FoxO, forkhead box protein; GDF11,
growth differentiation factor 11; HGF, hepatocyte growth factor; hVps34, Class III PI 3-kinase; IGF, insulin like growth factor; IL, interleukin; IRS-1, insulin receptor
substrate 1; MAFbx, muscle atrophy f-box; mTORC1, mammalian target of rapamycin complex 1; MuRF1, muscle RING finger 1; MRF, muscle regulatory factor;
MyoD, myogenic factor 3; MyoG, myogenic factor 4 (myogenin); NF-κB, nuclear factor kappa; NO, nitric oxide; Pax, paired box; PGC-1, peroxisome proliferator-
activated receptor gamma, coactivator 1; PI3k, phosphoinositid-3-kinase; PLD, phospholipase D; PLP, planar cell polarity; p70s6K, ribosomal protein S6 kinase;
REDD1, regulated in development and DNA damage responses; ROS, reactive oxygen species; RNS, reactive nitrogen species; SIRT-1, sirtuin 1; Smad, Smad
proteins homologs of mother against decapentaplegic (in Drosophila); TNF, tumor necrosis factor; UPS, ubiquitin-proteasome system; Wnt, signaling protein
(named after Wingless and Int-1 in Drosophila).
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NF-κB (Irrcher et al., 2008). Overall, ROS/RNS play an important
role in regulating their own defense by promoting cellular
antioxidants. They also contribute to the endurance phenotype by
activation of NF-κB and induction of PGC-1α.
Long-chain fatty acids and the peroxisome-proliferator activated
receptor system
Intracellular free long-chain fatty acids (LCFAs; saturated and
unsaturated) regulate energy metabolism by acting as ligands to the
nuclear receptor family of transcription factors PPAR (peroxisome-
proliferator activated receptors; PPARα, PPARγ and PPARδ; see
Nakamura et al., 2014). PPARα is mainly expressed in liver and is
instrumental in adaptation to fasting, inducing ketogenesis and beta-
oxidation in liver mitochondria. PPARγ is mainly active in
adipocytes, sensing and storing non-esterified LCFAs. PPARδ is
expressed ubiquitously but at particularly high levels in skeletal
muscle tissue. PPARδ is more expressed in oxidative than in
glycolytic fibers and its activation is crucial for the enhanced
reliance of muscle on LCFAs during fasting and in long-term
exercise. Starvation increases expression of PPARδ in skeletal
muscle, inducing its target genes forkhead box protein O1 (FOXO1)
and pyruvate dehydrogenase lipoamine kinase isoenzyme 4
(PDK4), the latter suppressing glycogen utilization by inactivating
pyruvate dehydrogenase. FOXO1 is a regulator of cell metabolism
inhibited by insulin and capable of inducing PGC-1α. Not
surprisingly, long-term endurance exercise and the concomitant
increase in LCFA also increase PPARδ in active skeletal muscle
fibers (Kannisto et al., 2006). This suggests that PPARδ is involved
in increasing lipid metabolism and mitochondrial biogenesis, the
hallmark events of endurance exercise.
There is evidence that TLR2 and TLR4 (toll-like receptors),
found in the sarcolemma of skeletal muscle fibers, can be activated
by LCFAs that circulate in elevated amounts during long-term
endurance exercise. Animal experiments using both endurance
running and heparin to elevate LCFAs show that TLR2 and TLR4
signaling is able to specifically activate p38 MAPK (p38 mitogen-
activated protein kinase) and JNK (c-Jun N-terminal kinase) but not
NF-κB (Zbinden-Foncea et al., 2012). It is thus likely that TLR2 and
TLR4 can contribute to endurance adaptations.
Hypoxia
Hypoxia is a major cellular stressor in all tissues, leading to
stabilization of hypoxia inducible factor 1 (HIF-1), which, under
normoxic conditions, is continuously degraded. HIF-1 is considered
to be the master regulator of oxygen homeostasis. The main target
genes of HIF-1 comprise erythropoietin, inducing erythropoiesis,
vascular endothelial growth factor (VEGF), leading to
angiogenesis, and various genes involved in promoting glucose
metabolism and glycolysis (Semenza, 2012). Based on these
systemic effects of HIF-1, various hypoxia exposure protocols in
endurance exercise are in use. By varying levels and exposure times
to hypoxia (or altitude) they aim at maximizing the benefit from
HIF-1 adaptation (see Millet et al., 2010). While local hypoxia in
working skeletal muscle was considered to be a prime candidate for
skeletal muscle adaptations (Terrados et al., 1990), the role of HIF
activation in long-term endurance training is currently unknown.
Based on circumstantial evidence, Lindholm et al. (2014) suggest
that endurance exercise training leads to suppression of the HIF-1
system by activating negative regulators of HIF-1 such as the major
HIF-1 prolyl hydroxylase 2 (PHD2), marking HIF-1 for the
ubiquitin-proteasome degradation pathway. The repression of
HIF-1 could attenuate PDK1 (pyruvate dehydrogenase lipoamide
kinase 1) expression, which, through activation of the pyruvate
dehydrogenase complex, would increase the capacity to utilize
oxygen in long-term endurance exercise training. In line with this
proposition is the finding that mice lacking skeletal muscle HIF-1
have an oxidative phenotype with elevated oxidative enzymes and
an increased capillarity combined with a constitutively increased
AMPK activity (Mason et al., 2007).
Stressors involved in angiogenesis
By necessity there is an extremely tight correlation between
mitochondrial content and capillary supply in muscle tissues
across species (Hoppeler and Kayar, 1988). It has long been held
that shear stress on endothelial cells induced by increased blood
flow as well as by active and passive stretch of muscle tissue is key
to the angiogenic response (Egginton et al., 1998; Hellsten and
Hoier, 2014). A pivotal role in angiogenesis is played by VEGF.
VEGF is involved in both shear-stress- and stretch-induced
angiogenesis. It is expressed in endothelial cells, pericytes and
muscle cells. Muscle cells have been shown to store VEGF in
vesicles that translocate to the sarcolemma during contraction to
release VEGF into the extracellular space (Hoier et al., 2013).
Active or passive exercise can increase interstitial VEGF levels
several-fold, with endothelial nitric oxide synthase having a role in
shear-stress-induced angiogenesis. Beta-adrenergic signaling
associated with exercise has been shown to induce VEGF
expression in muscle tissue via PGC-1α1 independent of the HIF
system (Chan and Arany, 2014). This further stresses the central role
played by PGC-1α in exercise-induced muscle plasticity.
Signaling in strength training and muscle maintenance
Muscle tissue is the main reservoir of proteins in all vertebrates.
Muscle mass is thus critically controlled in terms of protein
synthesis and degradation. mTORC1 is considered to be the key
regulator of translation initiation and elongation of protein synthesis
in muscle tissue. mTORC1 can be activated or depressed depending
on upstream signaling events whereby muscle mass seems to be
more regulated through modification of protein synthesis than
through changes in protein degradation (Phillips, 2009) (Fig. 2).
The mechanisms of mTORC1 activation through membrane-bound
receptors activated by insulin and growth factors are well described
and critical for all types of cells (see Dodd and Tee, 2012).
mTORC1 activation further depends on the complex regulation of
the intracellular amino acid pools. It is less well understood how
mechanical stimuli and leucine affect mTORC1 activation in
muscle cells. The presence of amino acids is necessary for growth-
factor-mediated activation of mTORC; however, leucine and in
particular mechanical stress are also capable of activating mTORC1
in the absence of growth factors.
Essential amino acids
Muscle myofibrillar protein synthesis is strongly dependent on
nutrient status, in particular the availability of essential amino acids.
The anabolic effect of ingested food depends mainly of the presence
of sufficient quantities of essential amino acids, in particular
leucine. The anabolic effect of essential amino acids seems to level
off at a total dose of 20–25 g protein day−1 (Tipton and Phillips,
2013). An oral bolus of whey protein has been shown to increase
muscle protein synthesis by 300% while muscle protein breakdown
is repressed by 50% in young men (Atherton et al., 2010). The
increase in muscle proteins synthesis rate is mirrored by mTORC1
activation at least during the first 90 min of the response. The fact
that the muscle protein synthesis rate decreases despite the
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continued presence of precursors in the blood stream has been
construed as a ‘muscle-full’ signal (Phillips, 2009). This author
further hypothesizes that muscle wasting syndromes, such as
sarcopenia in old age, cancer or other diseases, may be due to an
early ‘muscle full’ signal.
Mechanical signaling
As mentioned above, skeletal muscle mass depends strongly on
mechanical stress. High load exercise (>60% one repetition
maximum) can activate mTORC1 via several pathways.
Mechanical stress generated in sarcomeres is transferred to the
extracellular matrix via focal adhesions, where the actin
cytoskeleton is connected via linker proteins to the extracellular-
matrix-bound trans-membranous integrins. Changes in mechanical
stress are responsible for changes in the multi protein complexes
(called costameres in skeletal muscle) involved in mechano-
transduction and mechano-sensing, notably focal adhesion kinase
(FAK) (Goldmann, 2014; Janoštiak et al., 2014). A critical role in
the costamere complex is attributed to FAK, as it has been shown
that FAK is required for IGF-1-mediated muscle growth (Crossland
et al., 2013). FAK has also been implicated in load-dependent
turnover of costameres, with both decreased activity (bedrest) and
increased activity (resistance training; Li et al., 2013). In this
context, FAK has been identified as a protein kinase B (Akt)-
independent mechano-sensing pathway, capable of directly
activating ribosomal protein S6 kinase (p70S6K; Klossner et al.,
2009).
Activation of satellite cells
Satellite cells located beneath the basal lamina of muscle cells are
instrumental for growth and repair of muscle tissue. Satellite cells
are a heterogeneous population of cells with the majority of cells
being committed, satellite myogenic cells, which, upon stimulation,
undergo symmetric division and differentiation. A smaller number
of satellite cells (satellite stem cells) undergo asymmetric division,
repopulate the satellite cell niche and maintain long-term muscle
regenerative potential. The behavior of satellite cells is controlled by
a complex interplay of the molecular constitution of satellite cells
themselves as well as extrinsic local and systemic factors affecting
the satellite cells in their niche (see Yin et al., 2013). The satellite
cell niche harbors a number of growth factors in precursor form,
such as hepatocyte growth factor, fibroblast growth factor,
epidermal growth factor and insulin-like growth factors (IGF-I
and IGF-II) that can rapidly be activated in particular after muscle
injury. Satellite cells are under neural influence, as nerve growth
factor and brain-derived neurotropic factor seem to play a role
in muscle development and satellite cell maintenance. There
is evidence for cross-talk between satellite cells and the
microvasculature with both VEGF and NO synthase signaling
reported in muscle regeneration.
In humans, strength training resulting in an increase of muscle
fiber cross-sectional area also leads to an increase in satellite cell
number (Kadi et al., 2004), whereby modest gains in muscle fiber
size seem to be possible without the integration of satellite cells into
the muscle fibers. In mice, the increase in satellite cell number and
fiber size has been shown to be related toWnt signaling activated by
Wnt binding to Frizzled receptors. Wnt signaling involves a Wnt/
β-catenin and a Wnt/planar cell polarity pathway and is further
linked to the Akt/mTOR axis (Bentzinger et al., 2014). The second
major pathway involved in satellite cell proliferation and
differentiation is the Notch pathway activated by the ligand Delta.
This pathway seems to be particularly important for muscle
regeneration after injury (Yin et al., 2013). Androgens promote
satellite cell activation and proliferation possibly through Notch
signaling and further support muscle hypertrophy by elevating IGF-
1 levels and suppressing myostatin via follistatin (see Sinha-Hikim
et al., 2006).
Negative regulators of muscle mass
Muscle atrophy occurs in isolated muscles with inactivity and
denervation. The loss of muscle mass as a systemic response occurs
in severe disease states such as sepsis, AIDS, cardiac failure, chronic
obstructive pulmonary disease (COPD), glucocorticoids (Cushing
syndrome), diabetes, burns and trauma. Muscle wasting is a
prominent symptom in most patients with cancer (cachexia) and
happens inevitably in old age (sarcopenia; see Cohen et al., 2015).
Common to these conditions is the activation of a number of
catabolic stimuli that increase the protein degradation by the
ubiquitin-proteasome system (UPS) and by autophagy, as well
as through suppression of anabolic pathways. Myofibrillar
components are mostly attacked by the UPS (loss of contractile
force), while mitochondria and soluble proteins are preferentially
degraded by autophagy (loss of endurance capacity). In humans,
muscle wasting conditions contribute to mortality and to the loss of
quality of life; research into the mechanisms of muscle atrophy has
therefore received much recent attention (Dutt et al., 2015).
Myostatin, activin A and growth differentiation factor 11
All three proteins bind to ActRIIA/B (activin type two receptors),
which in turn phosphorylate and activate the Smad complex,
particularly Smad2 and Smad3, considered to be key players in
muscle atrophy. An exception is Smad7, which functions as a
negative feedback inhibiting myostatin signaling (see Rodriguez
et al., 2014). The best researched of the proteins binding to
ActRIIA/B is myostatin. It is a potent player in muscle mass
homoeostasis, negatively influencing protein synthesis and
activating catabolic pathways. It is suggested that myostatin
negatively influences the Akt/mTOR axis directly as well as
through the Smad protein complex. Myostatin also suppresses bone
morphogenic protein signaling, this protein being a potent promoter
of muscle hypertrophy, at least in mice (Sartori et al., 2013).
Circumstantial evidence strongly suggests a role of myostatin in
muscle protein breakdown through both the ubiquitin-proteasome
and the autophagy pathways. However, the role of myostatin in
muscle atrophy is less well understood. The direct activation of
FoxO and increased FoxO activity through suppression of the Akt/
mTOR axis has been proposed to explain the role of myostatin in
muscle protein degradation (Rodriguez et al., 2014). Myostatin and
growth differentiation factor 11 (GDF11) seem to be important in
humans as both increase in disease states and with age. GDF11 has
been shown to inhibit muscle regeneration and to decrease satellite
cell expansion (Egerman et al., 2015).
Chronic inflammation
The presence of elevated levels of pro-inflammatory cytokines such
as tumor necrosis factor α, IL-1, IL-6 and others is the hallmark of
tumor cachexia but is also observed in other chronic diseases that
lead to muscle wastage, not least in old-age-associated sarcopenia
(Cohen et al., 2015). Chronically elevated levels of pro-
inflammatory cytokines activate NF-κB, which leads to increased
transcription of atrogens. Moreover, chronic inflammation is also
known to increase myostatin levels, thus activating the FoxO and
Smad complexes. In contrast to the damage done by chronically
elevated levels of pro-inflammatory cytokines, the intermittent
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increase of these factors with acute exercise plays a role in
promoting favorable muscle adaptations with exercise training
(Beiter et al., 2015).
Glucocorticoids
A number of disease conditions (among them sepsis, cachexis,
starvation, stress and insulinopenia) are associated with high levels
of circulating glucocorticoids. Additionally, glucocorticoids are
used to treat many chronic inflammatory diseases and are used as
immunosuppressants after organ transplantations. Muscle wastage
is observed as an important consequence of continuously elevated
levels of glucocorticoids. Glucocorticoids generally suppress
mTORC1 by activating REDD1 (regulated in development and
DNA damage response 1), which explains their inhibitory action on
protein synthesis. Glucocorticoids have been observed to directly
stimulate the transcription of FoxO, thus leading to an increased
transcription of atrogens, in particular muscle RING finger 1 and
Atrogin1. Glucocorticoids have also been shown to increase levels
of myostatin both by increasing myostatin transcription and by post-
transcriptional modifications (see Schakman et al., 2013).
Hypoxia
Systemic hypoxia has long been established as a negative regulator
of muscle mass. In COPD, hypoxia is believed to be a major factor
for the debilitating muscle wastage of this disease. Likewise,
environmental hypoxia is held responsible in muscle atrophy
observed with permanent sojourn at high altitude >5000 m (Howald
and Hoppeler, 2003). Hypoxia and other stress signals influence a
REDD1– mTORC1 feedback loop. Active mTORC1 inhibits the
UPP-dependent degradation of REDD1. Hypoxia transcriptionally
induces REDD1, leading to mTORC1 inhibition, leading to a
concomitant increase in REDD1 degradation. The REDD1–
mTORC1 feedback loop thus limits the inhibitory action of
REDD1 on mTORC1 (Tan and Hagen, 2013).
There is recent evidence that muscle hypertrophic responses can
be obtained by low-intensity resistance exercise (20–50% one
repetition maximum) combined with blood flow restriction to the
working muscle. The molecular mechanisms responsible in this
context have not yet been established but may be related to the
hypoxia stimulus being intermittent and localized (Scott et al.,
2014).
Ethanol
Acute alcohol intoxication and chronic alcohol abuse affect many
organ systems partly due to a state of increase in pro-inflammatory
cytokines and damage related to elevated levels of ROS. It has been
suggested that the cytokines and ROS are produced by activated
Kupffer cells exposed to intestinal bacteria that reach the liver in
abundance due to an ethanol-induced increase in gut permeability
(González-Reimers et al., 2014). As a consequence, muscle wastage
associated with alcohol abuse follows the pattern described for
chronically elevated cytokine levels in the preceding paragraphs. In
addition, alcohol abuse is also shown to lead to a direct reduction of
mTORC1 activity via poorly understood mechanisms (Steiner and
Lang, 2015).
Summary and comparative perspective of muscle plasticity
The present synopsis gives a brief, incomplete and tentative
overview of the currently known molecular mechanisms involved
in skeletal muscle plasticity and their interdependence. In addition
to the transcriptional and translational signaling networks involved
with skeletal muscle plasticity described in this review, there are
additional levels of control, not discussed, such as microRNAs that
are capable of targeted post-transcriptional silencing of genes
(Kirby et al., 2015) and epigenetic modifications of DNA that are
involved in acute, long-term and transgenerational tuning of skeletal
muscle gene expression (Moresi et al., 2015).
It is noted that two key characteristics of muscle tissue, namely
endurance and strength, are governed by controls at different levels
of the gene to protein axis. Endurance capacity, closely related to the
capacity of skeletal muscle tissue to use oxygen for regeneration of
ATP, is dominantly controlled on the level of gene transcription.
The central activator of mitochondrial biogenesis and angiogenesis,
the transcriptional coactivator PGC-1α, is orchestrating the
transcriptional activation of hundreds of genes. As indicated in
Fig. 1, at least six independent but interrelated signaling pathways
are responsible for activating PGC-1α. Strength is related to muscle
bulk, which is dominantly controlled by the activity of the
translational machinery, with mTORC1 considered to be the key
governor of muscle protein synthesis (Fig. 2). Several activating
pathways are impinging on mTORC1, of which growth factors,
mechanical signaling and amino acid availability are the most
prominent. Satellite cell activation is also part of an interrelated
signaling network controlling muscle mass in development and in
the adult state. However, mTORC1 has also a number of potent
negative regulators responsible for muscle wastage in various
diseases and in old age. Additionally, there is cross-talk between
strength and endurance signaling in muscle tissue as a number of
factors are common to both pathways.
From an evolutionary perspective we can surmise that the
pathways outlined in Figs 1 and 2 involved in skeletal muscle
plasticity, as incomplete and premature as they may be, are highly
conserved among animal species (Croce and McClay, 2009). Much
of the research on muscle signaling has been done in genetically
engineered mice and in C2C12 muscle cell cultures (derived from
mice). It has been suggested that the topology of the muscle
signaling networks are very similar in mammals, probably also in
vertebrates, and thus, in a general sense, are applicable to humans
(Baldwin et al., 2013). The massive research effort to unravel the
molecular mechanisms of muscle plasticity in animal model
systems and cell culture experiments implies the expectation that
similar exercise stress on muscle tissue should lead to similar
changes in muscle function and structure at least across mammalian
species. However, this is not what is observed. Endurance exercise
training in rats leads to an increase of myoglobin in the trained
muscles (Pattengale and Holloszy, 1967). In humans, normoxic
endurance training has no effect on muscle myoglobin content
(Masuda et al., 2001); to increase myoglobin concentration in
human muscle an additional hypoxic stimulus is necessary
(Desplanches et al., 2014). In humans, mitochondrial content in
the vastus lateralis muscle and endurance capacity are completely
unaffected by 4 weeks of a high fat diet (Vogt et al., 2003). By
contrast, high fat diets increase muscle oxidative capacity and
endurance in exercising and sedentary rodents (Lee et al., 2001).
Even more striking examples of skeletal muscle plasticity are
presented by migratory birds. For the semipalmated sandpiper
(Calidris pusilla), Maillet and Weber (2007) observed a massive
increase in muscle oxidative enzyme activity immediately
preceding the sandpipers’ migratory flight from Canada to South
America. The authors relate this change to the consumption of an
amphipod, containing high amounts of n-3 polyunsaturated fatty
acids. In later laboratory experiments it was shown that unsaturated
dietary fatty acids could increase oxidative enzymes by up to 90% in
sedentary quail muscles, whereby observed functional changes
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were attributed to changes in membrane fluidity and PPAR
expression (Nagahuedi et al., 2009). Observations on migratory
birds further indicate that flight muscle mass changes seasonally by
up to 40% in red knots, Calidris canutus, kept in captivity, under
constant photoperiod and without evidence of exercise training
(Dietz et al., 1999; Pierce and McWilliams, 2014). Similar seasonal
variation (unrelated to exercise) in muscle mass and composition of
fat and muscle tissue have also been observed in migratory bats
(McGuire et al., 2013).
The comparative examples indicate that the enormous
malleability of skeletal muscle mass and composition essentially
depends on the specific (seasonal) requirements of a species.
Muscle bulk and composition can be changed without invoking
endurance or strength training paradigms, depending on the needs of
a species. Available signaling networks can be invoked by any
adequate internal or external cue. Conceptually speaking, signaling
controlling muscle composition (Fig. 1) and signaling controlling
muscle mass (Fig. 2) are set up in a similar fashion. Several
signaling cascades depend on ‘sensor’ systems that inform muscle
cells about changes in the muscle external or internal milieu
impinging on the master regulators PCC-1α and mTORC1,
respectively. The signaling cascades are interrelated arranged in a
network with multiple nodes including feedback and feedforward at
various levels, making these networks resilient to perturbations. As
the general topology of the signaling network is evolutionary
conserved, it can be speculated that different species have tuned
these networks according to their specific needs using different cues
to modify muscle mass and composition. A consequence of this
would be that there is considerable species specificity in phenotypic
malleability of muscle tissue. Model organisms may therefore be
mainly useful for establishing the general qualitative layout of the
relevant signaling networks that enable this plasticity but are unable
to provide answers as to how individual species make use of the
available pathways.
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Gomez-Cabrera, M.-C., Borrás, C., Pallardó, F. V., Sastre, J., Ji, L. L. and Viña, J.
(2005). Decreasing xanthine oxidase-mediated oxidative stress prevents useful
cellular adaptations to exercise in rats. J. Physiol. 567, 113-120.
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